Subscribe
ca-ssis
ca-ssis / iStockphoto.com
16 January 2019Americas

FDA announces new measures to boost gene therapy innovation

The US Food and Drug Administration (FDA) has announced new policies to advance the development of safe and effective cell and gene therapies.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
FDA approved record number of novel devices in 2018
31 January 2019   A record number of novel devices were approved by the US Food and Drug Administration in 2018, the federal agency has said.
Biotechnology
FDA releases plan to boost biosimilars development
13 December 2018   The US Food and Drug Administration has announced new measures to advance the development of biosimilar medicines.


Editor's picks

‘We created law’: G1/24 and the creation of the ‘diamond standard’
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025

Editor's picks

Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

More on this story

Americas
FDA approved record number of novel devices in 2018
31 January 2019   A record number of novel devices were approved by the US Food and Drug Administration in 2018, the federal agency has said.
Biotechnology
FDA releases plan to boost biosimilars development
13 December 2018   The US Food and Drug Administration has announced new measures to advance the development of biosimilar medicines.

More on this story

Americas
FDA approved record number of novel devices in 2018
31 January 2019   A record number of novel devices were approved by the US Food and Drug Administration in 2018, the federal agency has said.
Biotechnology
FDA releases plan to boost biosimilars development
13 December 2018   The US Food and Drug Administration has announced new measures to advance the development of biosimilar medicines.

More features

‘We created law’: G1/24 and the creation of the ‘diamond standard’
BMS unit loses cell therapy patent at European Patent Office
Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market
Lord Justice Birss to become chancellor of the High Court
Bankruptcy judge approves $305m sale of genetics testing company
Sanofi successfully challenges rare disease patent in Europe
Bayer appoints new head of IP
WATCH: Policy direction—where are we now?